Literature DB >> 27423401

Systems Glycobiology: Integrating Glycogenomics, Glycoproteomics, Glycomics, and Other 'Omics Data Sets to Characterize Cellular Glycosylation Processes.

Sandra V Bennun1, Deniz Baycin Hizal1, Kelley Heffner1, Ozge Can2, Hui Zhang3, Michael J Betenbaugh4.   

Abstract

The number of proteins encoded in the human genome has been estimated at between 20,000 and 25,000, despite estimates that the entire proteome contains more than a million proteins. One reason for this difference is due to many post-translational modifications of protein that contribute to proteome complexity. Among these, glycosylation is of particular relevance because it serves to modify a large number of cellular proteins. Glycogenomics, glycoproteomics, glycomics, and glycoinformatics are helping to accelerate our understanding of the cellular events involved in generating the glycoproteome, the variety of glycan structures possible, and the importance of roles that glycans play in therapeutics and disease. Indeed, interest in glycosylation has expanded rapidly over the past decade, as large amounts of experimental 'omics data relevant to glycosylation processing have accumulated. Furthermore, new and more sophisticated glycoinformatics tools and databases are now available for glycan and glycosylation pathway analysis. Here, we summarize some of the recent advances in both experimental profiling and analytical methods involving N- and O-linked glycosylation processing for biotechnological and medically relevant cells together with the unique opportunities and challenges associated with interrogating and assimilating multiple, disparate high-throughput glycosylation data sets. This emerging era of advanced glycomics will lead to the discovery of key glycan biomarkers linked to diseases and help establish a better understanding of physiology and improved control of glycosylation processing in diverse cells and tissues important to disease and production of recombinant therapeutics. Furthermore, methodologies that facilitate the integration of glycomics measurements together with other 'omics data sets will lead to a deeper understanding and greater insights into the nature of glycosylation as a complex cellular process.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Chinese hamster ovary; N-glycosylation; glycans; glycoinformatics; systems biology

Mesh:

Substances:

Year:  2016        PMID: 27423401     DOI: 10.1016/j.jmb.2016.07.005

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   6.151


  14 in total

Review 1.  Leveraging advances in biology to design biomaterials.

Authors:  Max Darnell; David J Mooney
Journal:  Nat Mater       Date:  2017-11-24       Impact factor: 43.841

2.  Glycans, Glycosite, and Intact Glycopeptide Analysis of N-Linked Glycoproteins Using Liquid Handling Systems.

Authors:  Shao-Yung Chen; Mingming Dong; Ganglong Yang; Yangying Zhou; David J Clark; T Mamie Lih; Michael Schnaubelt; Zichen Liu; Hui Zhang
Journal:  Anal Chem       Date:  2020-01-03       Impact factor: 6.986

Review 3.  What is the Sugar Code?

Authors:  Hans-Joachim Gabius; Maré Cudic; Tammo Diercks; Herbert Kaltner; Jürgen Kopitz; Kevin H Mayo; Paul V Murphy; Stefan Oscarson; René Roy; Andreas Schedlbauer; Stefan Toegel; Antonio Romero
Journal:  Chembiochem       Date:  2021-09-22       Impact factor: 3.461

Review 4.  Cancer systems immunology.

Authors:  Nathan E Reticker-Flynn; Edgar G Engleman
Journal:  Elife       Date:  2020-07-13       Impact factor: 8.140

5.  Comparison of Enrichment Methods for Intact N- and O-Linked Glycopeptides Using Strong Anion Exchange and Hydrophilic Interaction Liquid Chromatography.

Authors:  Weiming Yang; Punit Shah; Yingwei Hu; Shadi Toghi Eshghi; Shisheng Sun; Yang Liu; Hui Zhang
Journal:  Anal Chem       Date:  2017-10-12       Impact factor: 6.986

Review 6.  Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy.

Authors:  Austin W T Chiang; Hratch M Baghdassarian; Benjamin P Kellman; Bokan Bao; James T Sorrentino; Chenguang Liang; Chih-Chung Kuo; Helen O Masson; Nathan E Lewis
Journal:  J Biomed Sci       Date:  2021-06-22       Impact factor: 8.410

Review 7.  Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?

Authors:  Rita Azevedo; Andreia Peixoto; Cristiana Gaiteiro; Elisabete Fernandes; Manuel Neves; Luís Lima; Lúcio Lara Santos; José Alexandre Ferreira
Journal:  Oncotarget       Date:  2017-07-21

8.  ST3Gal3 confers paclitaxel‑mediated chemoresistance in ovarian cancer cells by attenuating caspase‑8/3 signaling.

Authors:  Xian Zhang; Xinying Yang; Ming Chen; Shaolie Zheng; Jinyuan Li; Shaoqiang Lin; Xiaoyu Wang
Journal:  Mol Med Rep       Date:  2019-09-26       Impact factor: 2.952

Review 9.  Towards a standardized bioinformatics infrastructure for N- and O-glycomics.

Authors:  Miguel A Rojas-Macias; Julien Mariethoz; Peter Andersson; Chunsheng Jin; Vignesh Venkatakrishnan; Nobuyuki P Aoki; Daisuke Shinmachi; Christopher Ashwood; Katarina Madunic; Tao Zhang; Rebecca L Miller; Oliver Horlacher; Weston B Struwe; Yu Watanabe; Shujiro Okuda; Fredrik Levander; Daniel Kolarich; Pauline M Rudd; Manfred Wuhrer; Carsten Kettner; Nicolle H Packer; Kiyoko F Aoki-Kinoshita; Frédérique Lisacek; Niclas G Karlsson
Journal:  Nat Commun       Date:  2019-07-22       Impact factor: 14.919

10.  Promiscuity and specificity of eukaryotic glycosyltransferases.

Authors:  Ansuman Biswas; Mukund Thattai
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.